Royce & Associates’s QuidelOrtho QDEL Stock Holding History
Bought
Maintained
Sold
Other funds holding QDEL
RCMNY
Royce & Associates's QDEL Position: Q2 2025 in Review
Royce & Associates sold out of QuidelOrtho (QDEL) in Q2 2025, closing a stake of 66,391 shares — an estimated $2.32M sold.
Royce & Associates first reported a position in QDEL in Q2 2013 and held it in 20 quarters. The position peaked at $13.4M in Q4 2022. 264 funds tracked by Wall St. Rank hold QDEL as of Q2 2025.
- Royce & Associates reported no remaining QuidelOrtho position as of Q2 2025 after selling out during the quarter.
- Royce & Associates sold 66,391 QuidelOrtho shares in Q2 2025, an estimated $2.32M.
- Royce & Associates first reported a position in QuidelOrtho in Q2 2013 and held it in 20 quarters.
- Royce & Associates's QuidelOrtho position peaked at $13.4M in Q4 2022.
- 264 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2025.
Based on Royce & Associates's 13F filing for Q2 2025, filed 11 Aug 2025.